Pharmafile Logo
Pharmafocus logo
Advanced Search
ABPI image

VBP will be ‘unfair’: report

May 8, 2013
Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP

A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …

News
astrazeneca image

AstraZeneca reveals Alderley Park plan

May 8, 2013
Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

News
mary_s

New UK head at Porter Novelli

May 8, 2013
Medical Communications, Sales and Marketing Porter Novelli, smiddy

PR firm Porter Novelli has announced that Mary Smiddy has been named as its new UK head of health & …

Appointment
J&J, image

Asian regulators take issue with J&J facilities

May 7, 2013
Manufacturing and Production India, J&J, JJ, Korea, inspection

Johnson & Johnson’s manufacturing network is under yet more scrutiny following regulatory actions by authorities in India and South Korea. …

News

Funding boost for GSK open lab

May 7, 2013
Research and Development, Sales and Marketing GSK, Wellcome

GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …

News
Buffet image

Lessons from the business gurus

May 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus

Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …

Feature

FleishmanHillard appoints two directors

May 7, 2013
Medical Communications, Sales and Marketing FleishmanHillard

Comms firm FleishmanHillard has added two directors to its Healthcare leadership team. Robert Hanvik and Alison Wright have joined the …

Appointment
Merck image

FDA approves Liptruzet

May 7, 2013
Sales and Marketing FDA, Merck, liptruzet

Merck is celebrating after its once-daily anti-cholesterol pill Liptruzet was approved by US regulators, expanding its indications. The drug – …

News
Teva image

Teva says US facility will close in cost-cutting drive

May 3, 2013
Manufacturing and Production Teva, closure, cuts

Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …

News
Sanofi image

Sanofi’s performance dives

May 3, 2013
Sales and Marketing Q1, Sanofi

Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …

News
28569_guenter_100

Sanofi appoints two executive members

May 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …

Appointment

Lundbeck moves ahead in Q1

May 3, 2013
Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1

Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …

News
FDA image

FDA seeks manufacturing data for GSK’s trametinib

May 2, 2013
Manufacturing and Production FDA, GSK, melanoma

GlaxoSmithKline’s melanoma drug candidate trametinib has been delayed in the US by an FDA request for more information on its …

News
Boehringer image

Boehringer and OBT in cancer tie-up

May 2, 2013
Research and Development, Sales and Marketing Boehringer, Cancer, OBT

Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …

News
EMA image

Court rules against EMA disclosure

May 2, 2013
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency

The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …

News
professor_martin_gibson

Not-for-profit comms agency adds special advisor

May 1, 2013
Medical Communications, Sales and Marketing Comprehensive communications

A new not-for-profit marketing and comms consultancy that specialises in healthcare and research has added Professor Martin Gibson to its …

Appointment

GSK abandons Parkinson’s drug

May 1, 2013
Research and Development, Sales and Marketing GSK, IPX066, Parkinson's

GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …

News
Gilead image

Manufacturing issues block Gilead approvals

May 1, 2013
Manufacturing and Production FDA, Gilead

The FDA has blocked approval of two of Gilead Sciences’ HIV drugs because of deficiencies in their marketing applications related …

News
leigh

Life appoints new executive

May 1, 2013
Medical Communications, Sales and Marketing Anderson, Life

Creative comms agency Life Healthcare Communications has appointed a new account executive as part of the expansion of its client …

Appointment
MS Society web image

Charity: MS treatment is ‘lottery’

May 1, 2013
Sales and Marketing MS, lottery, society

Multiple sclerosis care in the UK is a ‘lottery’ according to research by the MS Society. The charity says that …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026